ATE327680T1 - Verfahren zur verbesserung der knochenmineralisierung - Google Patents

Verfahren zur verbesserung der knochenmineralisierung

Info

Publication number
ATE327680T1
ATE327680T1 AT01130895T AT01130895T ATE327680T1 AT E327680 T1 ATE327680 T1 AT E327680T1 AT 01130895 T AT01130895 T AT 01130895T AT 01130895 T AT01130895 T AT 01130895T AT E327680 T1 ATE327680 T1 AT E327680T1
Authority
AT
Austria
Prior art keywords
bone mineralization
improving bone
improving
mineralization
bone
Prior art date
Application number
AT01130895T
Other languages
English (en)
Inventor
John B Lasekan
Marc L Masor
Michael B Montalto
John D Benson
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23097261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE327680(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE327680T1 publication Critical patent/ATE327680T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Edible Oils And Fats (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01130895T 2001-04-24 2001-12-27 Verfahren zur verbesserung der knochenmineralisierung ATE327680T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28614001P 2001-04-24 2001-04-24

Publications (1)

Publication Number Publication Date
ATE327680T1 true ATE327680T1 (de) 2006-06-15

Family

ID=23097261

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01130895T ATE327680T1 (de) 2001-04-24 2001-12-27 Verfahren zur verbesserung der knochenmineralisierung

Country Status (14)

Country Link
US (2) US6620427B2 (de)
EP (1) EP1252824B1 (de)
JP (1) JP2002315503A (de)
AR (1) AR030834A1 (de)
AT (1) ATE327680T1 (de)
BR (1) BR0201023A (de)
CA (1) CA2357459C (de)
CY (1) CY1106141T1 (de)
DE (1) DE60120114T2 (de)
DK (1) DK1252824T3 (de)
ES (1) ES2265386T3 (de)
MX (1) MXPA01011436A (de)
PT (1) PT1252824E (de)
SA (1) SA02220671B1 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040013787A1 (en) * 2002-06-28 2004-01-22 Theuer Richard C. Fat compositions for infant formula and methods therefor
US8815279B2 (en) * 2003-02-10 2014-08-26 University College London Baby feeding formula and system
US20050175759A1 (en) * 2004-02-09 2005-08-11 Atul Singhal Newborn infant formulas and feeding methods
US7323200B2 (en) * 2003-08-18 2008-01-29 Abbott Laboratories Calcium fortified, soy based, infant nutritional formulas
IL158555A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
US20050129825A1 (en) * 2003-12-16 2005-06-16 Gray Kimberley H. Stabilization of milk-based products
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
JP4759289B2 (ja) * 2005-03-02 2011-08-31 国立大学法人北海道大学 カルシウム吸収促進組成物およびその利用
JP5227182B2 (ja) 2005-12-19 2013-07-03 アボット・ラボラトリーズ １型および２型サイトカイン産生における不均衡を調節するためのベータ−ヒドロキシ−ベータ−メチルブチラートの使用
EP1800675B1 (de) 2005-12-23 2011-05-18 N.V. Nutricia Zusammensetzung enthaltend mehrfach ungesättigte Fettsäuren, Proteine, Mangan und/oder Molybden und Nukleotide/Nukleoside, zur Behandlung von Demenz
US8753391B2 (en) 2007-02-12 2014-06-17 The Trustees Of Columbia University In The City Of New York Fully synthetic implantable multi-phased scaffold
US20080200425A1 (en) * 2007-02-16 2008-08-21 Kurtz Seymour J Methods and compositions for regulating bone mineral density
WO2008136420A1 (ja) * 2007-04-27 2008-11-13 Meiji Dairies Corporation ホエイタンパク質を高濃度で含む液状栄養組成物およびその製造方法
US20110274790A1 (en) * 2007-04-29 2011-11-10 Shemen Industries, Ltd. Nourishing oil composition for infants and young children
DE102007022694A1 (de) * 2007-05-11 2008-11-13 Humana Milchunion Eg Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme
US20090004715A1 (en) 2007-06-01 2009-01-01 Solazyme, Inc. Glycerol Feedstock Utilization for Oil-Based Fuel Manufacturing
IL184982A0 (en) 2007-08-01 2008-01-20 Enzymotec Ltd Edible fat composition for enhancing bone strength
CA2720828C (en) 2008-04-09 2017-03-21 Solazyme, Inc. Direct chemical modification of microbial biomass and microbial oils
CN104605359A (zh) * 2008-06-16 2015-05-13 N·V·努特里奇亚 具有脂肪梯度的组合物
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
WO2010027259A1 (en) 2008-09-02 2010-03-11 N.V. Nutricia Nutritional compositions with coated lipid globules
US20100303989A1 (en) 2008-10-14 2010-12-02 Solazyme, Inc. Microalgal Flour
US20160324167A1 (en) 2008-10-14 2016-11-10 Terravia Holdings, Inc. Novel microalgal food compositions
US20100297296A1 (en) * 2008-10-14 2010-11-25 Solazyme, Inc. Healthier Baked Goods Containing Microalgae
AU2009319722B2 (en) * 2008-11-28 2016-08-04 Corbion Biotech, Inc. Production of tailored oils in heterotrophic microorganisms
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
BR112012018174A2 (pt) 2010-01-29 2019-08-27 Abbott Lab líquidos nutricionais embalados assepticamente compreendendo hmb.
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
ES2481865T3 (es) 2010-01-29 2014-07-31 Abbott Laboratories Emulsiones nutricionales que comprenden HMB de calcio
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
US8592188B2 (en) * 2010-05-28 2013-11-26 Solazyme, Inc. Tailored oils produced from recombinant heterotrophic microorganisms
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
EP2635663B1 (de) * 2010-11-03 2019-05-08 Corbion Biotech, Inc. Mikrobielle öle mit redzuzierten giesspunkten, dielektrische flüssigkeiten daraus und zugehörige verfahren
KR101964965B1 (ko) 2011-02-02 2019-04-03 테라비아 홀딩스 인코포레이티드 재조합 유지성 미생물로부터 생산된 맞춤 오일
MX339607B (es) 2011-05-06 2016-05-31 Solazyme Inc Microorganismos geneticamente modificados que metabolizan xilosa.
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US8945908B2 (en) 2012-04-18 2015-02-03 Solazyme, Inc. Tailored oils
US9719114B2 (en) 2012-04-18 2017-08-01 Terravia Holdings, Inc. Tailored oils
US10098371B2 (en) 2013-01-28 2018-10-16 Solazyme Roquette Nutritionals, LLC Microalgal flour
US20160296664A1 (en) 2013-04-12 2016-10-13 The Trustees Of Columbia University In The City Of New York Methods for host cell homing and dental pulp regeneration
EP2993993A2 (de) 2013-04-26 2016-03-16 Solazyme, Inc. Öle mit niedrigem gehalt an mehrfach ungesättigten fettsäuren und verwendungen davon
FR3009619B1 (fr) 2013-08-07 2017-12-29 Roquette Freres Compositions de biomasse de microalgues riches en proteines de qualite sensorielle optimisee
MX369685B (es) 2013-10-04 2019-11-19 Terravia Holdings Inc Aceites adaptables.
ES2693519T3 (es) 2013-11-01 2018-12-12 N.V. Nutricia Composición lipídica para mejorar la composición corporal durante el crecimiento de recuperación
WO2015085549A1 (en) * 2013-12-12 2015-06-18 Nestec S.A. An age-tailored nutrition system for an infant
WO2015149026A1 (en) 2014-03-28 2015-10-01 Solazyme, Inc. Lauric ester compositions
US9969990B2 (en) 2014-07-10 2018-05-15 Corbion Biotech, Inc. Ketoacyl ACP synthase genes and uses thereof
WO2016066459A1 (en) * 2014-10-27 2016-05-06 Nestec S.A. Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children
KR101559937B1 (ko) * 2015-02-25 2015-10-14 주식회사 진용 홍화씨 추출물, 보스웰리아 추출물 및 황금 추출물을 유효성분으로 함유하는 뼈 길이 성장 촉진용 및 골밀도 증가용 식품 조성물
WO2017064304A1 (en) 2015-10-15 2017-04-20 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
CN109475166A (zh) * 2016-08-05 2019-03-15 雀巢产品技术援助有限公司 促进肠道舒适度以及最佳脂肪和钙吸收的用于婴儿和幼儿的脂质组合物
ES2987545T3 (es) 2016-12-09 2024-11-15 Nutricia Nv Composición nutricional para su uso en la mejora del rendimiento cognitivo y/o la prevención del deterioro cognitivo
JP6628946B2 (ja) 2017-12-26 2020-01-15 大太朗 福岡 増毛、頭皮若しくは皮膚の改質、創傷治癒、骨形成促進、または毛髪の改質に用いるための医薬組成物
US20240277739A1 (en) * 2021-07-01 2024-08-22 N.V. Nutricia Nutritonal compositions for gut barrier function

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649295A (en) * 1970-06-01 1972-03-14 American Home Prod Humanized fat compositions and infant formulas thereof
GB8317248D0 (en) * 1983-06-24 1983-07-27 Wyeth John & Brother Ltd Fat compositions
JPS61209544A (ja) * 1985-03-14 1986-09-17 Ueda Seiyu Kk 人乳脂類似油脂
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
US6136858A (en) 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
DE69718455T2 (de) * 1997-07-22 2003-04-30 Societe Des Produits Nestle S.A., Vevey Lipidzusammensetzung für Säuglingsnährpräparat und Herstellungsverfahren
JP2000023639A (ja) * 1998-05-06 2000-01-25 Yoshio Inoue マヨネーズ、ドレッシング、カレールウ、フライ、てんぷら、コロッケ、アイスクリームなどの脂肪が腸管から吸収されるのを抑制する方法
US6294206B1 (en) * 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
EP1062873A1 (de) * 1999-12-13 2000-12-27 N.V. Nutricia Verbessertes Säuglingsnährpräparat, Eiweisshydrolysat zur Verwendung in solchem Säuglingsnährpräparat, und Verfahren zur Herstellung solches Hydrolysates

Also Published As

Publication number Publication date
BR0201023A (pt) 2003-01-14
ES2265386T3 (es) 2007-02-16
MXPA01011436A (es) 2005-06-30
CA2357459A1 (en) 2002-10-24
EP1252824B1 (de) 2006-05-31
AR030834A1 (es) 2003-09-03
US6620427B2 (en) 2003-09-16
CY1106141T1 (el) 2011-06-08
EP1252824A3 (de) 2004-01-07
SA02220671B1 (ar) 2006-12-19
DK1252824T3 (da) 2006-10-02
JP2002315503A (ja) 2002-10-29
PT1252824E (pt) 2006-10-31
DE60120114D1 (de) 2006-07-06
DE60120114T2 (de) 2007-01-04
US6849268B2 (en) 2005-02-01
US20030026860A1 (en) 2003-02-06
US20040062820A1 (en) 2004-04-01
CA2357459C (en) 2010-02-02
EP1252824A2 (de) 2002-10-30

Similar Documents

Publication Publication Date Title
ATE327680T1 (de) Verfahren zur verbesserung der knochenmineralisierung
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
DE60235578D1 (de) Verfahren zur reifenuntersuchung
ATE298326T1 (de) Verfahren zur epoxidierung von olefinen
DE60237184D1 (de) Verfahren zur Erzeugung von Bewegungen
DE50212406D1 (de) Verfahren zur Aufnahme eines Objektraumes
ATE382631T1 (de) Verfahren zur herstellung von virusinaktiviertem humanem gammaglobulin g
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
ATE437486T1 (de) Verfahren zur konfiguration von physischen kanälen
DE60124884D1 (de) Verfahren zur verbesserung der fotomaskengeometrie
ATE384436T1 (de) Verfahren zur unkrautbekämpfung
DE60307617D1 (de) Verfahren zur gewinnung von gold
DE50205721D1 (de) Verfahren zur verteilreihenfolgesortierung
DE50209427D1 (de) Verfahren zur Entfernungsmessung
DE50206619D1 (de) Reinigungsmaschine und Verfahren zur Reinigung von Schotter
DE60202588D1 (de) Verfahren zur Rauschminderung
DE60104976D1 (de) Verfahren zur Bereitstellung von Dienstleistungen
DE60210911D1 (de) Verfahren zur Herstellung von dehnungserfassenden Vorrichtungen
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
ATE297909T1 (de) Verfahren zur epoxidierung von olefinen
DE60203514D1 (de) Verfahren zur zuteilung von stockwerkanrufen
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
DE50203864D1 (de) Verfahren zur Unterdrückung von Jammer-Signalen
DE50201799D1 (de) Verfahren zur gewinnung von n-phosphonomethylglycin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1252824

Country of ref document: EP